Kusajili – Clinical trials directory

Result of your search per sponsor: Steba Biotech S.A

Woman and Man Max 99 years
Steba Biotech S.A Update Il y a 4 ans

A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Related Macular Degeneration (AMD) To evaluate the safety and efficacy of treatment with WST11 (Stakel®) and Vascular-Targeted Photodynamic (VTP) therapy.

Country None
organs None
Specialty None

unknown

More information